Reaction Details |
| Report a problem with these data |
Target | Peroxisome proliferator-activated receptor delta |
---|
Ligand | BDBM50277931 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_502081 (CHEMBL983206) |
---|
EC50 | 678±n/a nM |
---|
Citation | Bénardeau, A; Benz, J; Binggeli, A; Blum, D; Boehringer, M; Grether, U; Hilpert, H; Kuhn, B; Märki, HP; Meyer, M; Püntener, K; Raab, S; Ruf, A; Schlatter, D; Mohr, P Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes. Bioorg Med Chem Lett19:2468-73 (2009) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Peroxisome proliferator-activated receptor delta |
---|
Name: | Peroxisome proliferator-activated receptor delta |
Synonyms: | NR1C2 | NUC1 | NUCI | Nuclear hormone receptor 1 | Nuclear receptor subfamily 1 group C member 2 | PPAR delta | PPAR-beta | PPARB | PPARD | PPARD_HUMAN | Peroxisome proliferator-activated receptor | Peroxisome proliferator-activated receptor beta | Peroxisome proliferator-activated receptor delta |
Type: | Enzyme |
Mol. Mass.: | 49910.45 |
Organism: | Homo sapiens (Human) |
Description: | Q03181 |
Residue: | 441 |
Sequence: | MEQPQEEAPEVREEEEKEEVAEAEGAPELNGGPQHALPSSSYTDLSRSSSPPSLLDQLQM
GCDGASCGSLNMECRVCGDKASGFHYGVHACEGCKGFFRRTIRMKLEYEKCERSCKIQKK
NRNKCQYCRFQKCLALGMSHNAIRFGRMPEAEKRKLVAGLTANEGSQYNPQVADLKAFSK
HIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKE
ISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNK
DGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGD
RPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRI
KKTETETSLHPLLQEIYKDMY
|
|
|
BDBM50277931 |
---|
n/a |
---|
Name | BDBM50277931 |
Synonyms: | (S)-3-(4-(2-(2-(3,5-dimethoxyphenyl)-5-methyloxazol-4-yl)ethoxy)benzo[b]thiophen-7-yl)-2-methoxypropanoic acid | CHEMBL521007 |
Type | Small organic molecule |
Emp. Form. | C26H27NO7S |
Mol. Mass. | 497.56 |
SMILES | CO[C@@H](Cc1ccc(OCCc2nc(oc2C)-c2cc(OC)cc(OC)c2)c2ccsc12)C(O)=O |r| |
Structure |
|